00203-5/asset/a0abd16a-3eaa-4d78-990d-ba94939c04c6/main.assets/gr2_lrg.jpg)
glp-1 agonist cardiovascular outcomes Cardiovascular, mortality, and kidney with receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials Targeting the weight within: obesity
Description
Kenakin says this is always a hazard: If you have an oral drug, the organ that receives the highest dose is the liver 50% of all drugs fail on liver toxicity, he says
A market can show strong starts while long-term continuation remains fragile
30249-9/asset/ae163e52-907c-4c99-987f-36b369e8996a/main.assets/gr3.gif)
N Engl J Med 384(12):11131124 Osaka T, Endo M, Yamakawa M, Inoue S (2005) Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system
This will be a huge field, Moore
Physiology and Behavior
95% CI, 0.96-3.85, respectively)
